Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Sell
31,246
-12,784
-29% -$4.38M 0.12% 103
2026
Q1
$15.5M Buy
44,030
+1,425
+3% +$508K 0.17% 65
2025
Q4
$13.9M Buy
42,605
+1,259
+3% +$399K 0.18% 68
2025
Q3
$11.7M Buy
41,346
+3,040
+8% +$882K 0.25% 69
2025
Q2
$10.7M Hold
38,306
– – 0.25% 76
2025
Q1
$11.9M Hold
38,306
– – 0.32% 65
2024
Q4
$9.93M Sell
38,306
-3,036
-7% -$901K 0.26% 79
2024
Q3
$13.3M Buy
41,342
+3,796
+10% +$1.24M 0.36% 57
2024
Q2
$11.7M Sell
37,546
-3,413
-8% -$1M 0.34% 57
2024
Q1
$11.6M Buy
+40,959
New +$12M 0.37% 62

Other funds holding AMGN

Allianz's AMGN Position: Q2 2026 in Review

Allianz reduced its Amgen (AMGN) stake by 29% in Q2 2026, selling an estimated $4.38M and leaving 31,246 shares worth $11.3M. The position accounts for 0.12% of the portfolio, ranked #103.

Allianz first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $15.5M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Allianz held 31,246 shares of Amgen worth $11.3M as of Q2 2026.
  • Allianz sold 12,784 Amgen shares in Q2 2026, an estimated $4.38M.
  • Amgen made up 0.12% of Allianz's portfolio in Q2 2026, its #103 holding.
  • Allianz first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Amgen position peaked at $15.5M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.